Numerous reports claim that quantum advantage, which should emerge as a direct consequence of the advent of quantum computers, will herald a new era of chemical research because it will enable scientists to perform the kinds of quantum chemical simulations that have not been possible before. Such simulations on quantum computers, promising a significantly greater accuracy and speed, are projected to exert a great impact on the way we can probe reality, predict the outcomes of chemical experiments, and even drive design of drugs, catalysts, and materials. In this work we review the current status of quantum hardware and algorithm theory and examine whether such popular claims about quantum advantage are really going to be transformative. We go over subtle complications of quantum chemical research that tend to be overlooked in discussions involving quantum computers. We estimate quantum computer resources that will be required for performing calculations on quantum computers with chemical accuracy for several types of molecules. In particular, we directly compare the resources and timings associated with classical and quantum computers for the molecules H$_2$ for increasing basis set sizes, and Cr$_2$ for a variety of complete active spaces (CAS) within the scope of the CASCI and CASSCF methods. The results obtained for the chromium dimer enable us to estimate the size of the active space at which computations of non-dynamic correlation on a quantum computer should take less time than analogous computations on a classical computer. Using this result, we speculate on the types of chemical applications for which the use of quantum computers would be both beneficial and relevant to industrial applications in the short term.
Numerous reports claim that quantum advantage, which should emerge as a direct consequence of the advent of quantum computers, will herald a new era of chemical research because it will enable scientists to perform the kinds of quantum chemical simulations that have not been possible before. Such simulations on quantum computers, promising a significantly greater accuracy and speed, are projected to exert a great impact on the way we can probe reality, predict the outcomes of chemical experiments, and even drive design of drugs, catalysts, and materials. In this work we review the current status of quantum hardware and algorithm theory and examine whether such popular claims about quantum advantage are really going to be transformative. We go over subtle complications of quantum chemical research that tend to be overlooked in discussions involving quantum computers. We estimate quantum computer resources that will be required for performing calculations on quantum computers with chemical accuracy for several types of molecules. In particular, we directly compare the resources and timings associated with classical and quantum computers for the molecules H2 for increasing basis set sizes, and Cr2 for a variety of complete active spaces (CAS) within the scope of the CASCI and CASSCF methods. The results obtained for the chromium dimer enable us to estimate the size of the active space at which computations of non-dynamic correlation on a quantum computer should take less time than analogous computations on a classical computer. Using this result, we speculate on the types of chemical applications for which the use of quantum computers would be both beneficial and relevant to industrial applications in the short term.
Computational chemistry is an essential tool in the pharmaceutical industry. Quantum computing is a fast evolving technology that promises to completely shift the computational capabilities in many areas of chemical research by bringing into reach currently impossible calculations. This perspective illustrates the near-future applicability of quantum computation of molecules to pharmaceutical problems. We briefly summarize and compare the scaling properties of state-of-the-art quantum algorithms and provide novel estimates of the quantum computational cost of simulating progressively larger embedding regions of a pharmaceutically relevant covalent protein-drug complex involving the drug Ibrutinib. Carrying out these calculations requires an error-corrected quantum architecture that we describe. Our estimates showcase that recent developments on quantum phase estimation algorithms have dramatically reduced the quantum resources needed to run fully quantum calculations in active spaces of around 50 orbitals and electrons, from estimated over 1000 years using the Trotterization approach to just a few days with sparse qubitization, painting a picture of fast and exciting progress in this nascent field.
The predictive simulation of molecules and materials has had a broad and significant impact. It nevertheless remains constrained by the cost of accurately treating electronic correlation, excited states, and complex energy landscapes. Quantum computing offers a fundamentally different computational paradigm in which quantum states are encoded and manipulated directly rather than approximated on classical hardware. Here we discuss where this approach may provide a genuine scientific advantage in chemistry, materials science, and biochemistry. Promising directions include the high-accuracy treatment of correlated active spaces, improved excited-state simulations, and accelerated exploration of combinatorial structure spaces. The central challenge is therefore not qubit scaling alone, but demonstrably chemically meaningful gains in predictive reliability. We argue that near-term value is most likely to come from disciplined workflow integration rather than wholesale replacement of classical methods. Noisy physical devices, error-mitigated utility experiments, early fault-tolerant devices, and fully fault-tolerant quantum computers offer different scientific prospects, and claims of usefulness must be tied to the specific regime being discussed. Quantum computing will become scientifically valuable when it demonstrably reduces uncertainty in computed energies, rates, spectra, or materials stability after the full costs of state preparation, measurement, error handling, and coupling to classical simulation are included.
Chemical process design has for long been benefiting from computer-aided methods and tools to develop new processes and services that can meet the needs of society. Chemical and biomolecular product design could also benefit from the use of computer-aided solution strategies and computational power to efficiently solve the problems at various scales as the complexity and size of problems grow. In this context, new modes of computation such as quantum computing are receiving increasing attention. While quantum computing has been in development for quite some time, the development of the technology to the point of making commercial use of such resources is quite recent, and still quite limited in scope. However, projections point to a rapid development of quantum computing resources becoming available to academia and industry, which opens potential application areas in chemical and biomolecular product design. With the advent of hybrid algorithms that are able to take advantage of both classical computing and quantum computing resources, as quantum computing grows, more and more problems relevant for chemical product design will become solvable. In this paper, some perspectives are given by identifying a set of needs and challenges for a selected set of opportunities, such as quantum chemistry-based property prediction, protein folding, complex multi-step chemical reactions, and molecular reaction dynamics.
Abstract Within the last decade much progress has been made in the experimental realization of quantum computing hardware based on a variety of physical systems. Rapid progress has been fuelled by the conviction that sufficiently powerful quantum machines will herald enormous computational advantages in many fields, including chemical research. A quantum computer capable of simulating the electronic structures of complex molecules would be a game changer for the design of new drugs and materials. Given the potential implications of this technology, there is a need within the chemistry community to keep abreast with the latest developments as well as becoming involved in experimentation with quantum prototypes. To facilitate this, here we review the types of quantum computing hardware that have been made available to the public through cloud services. We focus on three architectures, namely superconductors, trapped ions and semiconductors. For each one we summarize the basic physical operations, requirements and performance. We discuss to what extent each system has been used for molecular chemistry problems and highlight the most pressing hardware issues to be solved for a chemistry‐relevant quantum advantage to eventually emerge.
Accurate prediction of molecular structures and properties is vital for chemistry; materials science, and drug discovery, yet classical electronic-structure methods often fail for strongly correlated systems, large basis sets, and complex potential-energy landscapes. Quantum technology encompassing quantum computing, quantum machine learning, and hybrid quantum classical strategies offers a fundamentally new paradigm by encoding many-electron wave functions directly on qubits and exploiting superposition and entanglement to explore exponentially large Hilbert spaces. This review synthesizes recent algorithmic and hardware advances relevant to molecular modelling, including the Variational Quantum Eigensolver (VQE), Quantum Phase Estimation (QPE), quantum unitary coupled-cluster (q-UCC) families, equation-of-motion and subspace methods for excited states, tensor-network hybrids, and quantum kernel and variational QML approaches. We examine noise-aware hybrid workflows, error-mitigation techniques, symmetry-preserving ansätze, and operator-factorization methods that reduce measurement and gate overhead. Representative applications are discussed: ground- and excited-state energy prediction, potential-energy surface mapping, geometry and transition-state optimization, spectroscopic property estimation (IR, UV–Vis, NMR, EPR), and reaction-dynamics scenarios where non-adiabatic effects and conical intersections dominate. Resource estimates and scaling analyses clarify current NISQ limitations qubit counts, circuit depth, shot complexity and delineate the roadmap to fault-tolerant QPE for chemical accuracy. We compare quantum approaches with classical baselines (DFT, CCSD (T), multireference methods), identifying domains where quantum methods already show promise (strong correlation, multi-reference dissociation, spin-state ordering) and where classical methods remain competitive. Finally, we highlight near-term industrial opportunities in drug design, catalysis, CO2 capture, and energy materials, and outline critical research directions: algorithmic reductions in measurement/precision cost, hardware improvements in fidelity and connectivity, scalable ansatz design, and integrated software stacks for reproducible hybrid simulations. Together, these developments indicate that while practical, large-scale quantum advantage for general chemistry remains future work, quantum technologies are rapidly maturing into powerful tools for targeted molecular problems that are intractable with existing classical techniques.
Quantum chemistry plays a crucial role in advancing fundamental understanding of chemical processes and driving innovation in energy, medicine, and materials science. Recent progress in quantum computing has opened new possibilities for molecular simulations that are beyond the practical limits of classical approaches. Academic studies have demonstrated hybrid Density Functional Theory (DFT) and Variational Quantum Eigensolver (VQE) benchmarks on small transition-metal systems, such as iron porphyrin and heme analogues, using current noisy intermediate-scale quantum (NISQ) hardware. Although full-scale simulations of complex biological systems such as the complete Cytochrome P450 (CYP450) active site remain a long-term goal due to limitations in qubit numbers, coherence times, and error correction, the underlying methodologies are now well established. At present, quantum chemistry applications in drug discovery remain largely experimental, and widespread practical medical impact is expected to require further technological advances over the next 5–10 years. Nevertheless, quantum software and algorithm development for chemical applications is progressing rapidly. This perspective summarizes recent advances in quantum computing algorithms, hardware, and software relevant to chemistry, and critically discusses the remaining challenges and opportunities for applying quantum computing to chemical problems, with particular emphasis on drug discovery and development.